nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP1A1—Dacarbazine—pancreatic cancer	0.129	0.176	CbGbCtD
Granisetron—CYP1A1—Tamoxifen—pancreatic cancer	0.103	0.14	CbGbCtD
Granisetron—CYP1A1—Erlotinib—pancreatic cancer	0.0873	0.119	CbGbCtD
Granisetron—CYP3A5—Tamoxifen—pancreatic cancer	0.0616	0.0838	CbGbCtD
Granisetron—CYP3A5—Erlotinib—pancreatic cancer	0.0524	0.0713	CbGbCtD
Granisetron—CYP3A5—Irinotecan—pancreatic cancer	0.0473	0.0643	CbGbCtD
Granisetron—CYP2D6—Tamoxifen—pancreatic cancer	0.0378	0.0514	CbGbCtD
Granisetron—CYP3A5—Docetaxel—pancreatic cancer	0.0347	0.0472	CbGbCtD
Granisetron—CYP3A5—Sunitinib—pancreatic cancer	0.0345	0.0469	CbGbCtD
Granisetron—HTR3A—enteric nervous system—pancreatic cancer	0.0335	0.749	CbGeAlD
Granisetron—CYP2D6—Erlotinib—pancreatic cancer	0.0321	0.0437	CbGbCtD
Granisetron—CYP3A4—Tamoxifen—pancreatic cancer	0.024	0.0327	CbGbCtD
Granisetron—CYP3A4—Erlotinib—pancreatic cancer	0.0204	0.0278	CbGbCtD
Granisetron—CYP3A4—Irinotecan—pancreatic cancer	0.0184	0.0251	CbGbCtD
Granisetron—CYP2D6—Doxorubicin—pancreatic cancer	0.0158	0.0216	CbGbCtD
Granisetron—CYP3A4—Docetaxel—pancreatic cancer	0.0135	0.0184	CbGbCtD
Granisetron—CYP3A4—Sunitinib—pancreatic cancer	0.0135	0.0183	CbGbCtD
Granisetron—CYP3A4—Doxorubicin—pancreatic cancer	0.0101	0.0137	CbGbCtD
Granisetron—HTR3A—islet of Langerhans—pancreatic cancer	0.0032	0.0716	CbGeAlD
Granisetron—HTR3A—digestive system—pancreatic cancer	0.00192	0.043	CbGeAlD
Granisetron—CYP3A5—islet of Langerhans—pancreatic cancer	0.00159	0.0357	CbGeAlD
Granisetron—CYP3A5—pancreas—pancreatic cancer	0.00112	0.0251	CbGeAlD
Granisetron—CYP1A1—digestive system—pancreatic cancer	0.000978	0.0219	CbGeAlD
Granisetron—CYP3A5—digestive system—pancreatic cancer	0.000956	0.0214	CbGeAlD
Granisetron—CYP3A4—digestive system—pancreatic cancer	0.000718	0.0161	CbGeAlD
Granisetron—CYP2D6—digestive system—pancreatic cancer	0.000706	0.0158	CbGeAlD
Granisetron—Nausea—Erlotinib—pancreatic cancer	0.000274	0.00124	CcSEcCtD
Granisetron—Decreased appetite—Fluorouracil—pancreatic cancer	0.000274	0.00124	CcSEcCtD
Granisetron—Diarrhoea—Sunitinib—pancreatic cancer	0.000273	0.00124	CcSEcCtD
Granisetron—Dysgeusia—Docetaxel—pancreatic cancer	0.000273	0.00124	CcSEcCtD
Granisetron—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000272	0.00123	CcSEcCtD
Granisetron—Abdominal distension—Epirubicin—pancreatic cancer	0.000272	0.00123	CcSEcCtD
Granisetron—Feeling abnormal—Irinotecan—pancreatic cancer	0.000271	0.00123	CcSEcCtD
Granisetron—Pain—Fluorouracil—pancreatic cancer	0.00027	0.00122	CcSEcCtD
Granisetron—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000269	0.00122	CcSEcCtD
Granisetron—Eosinophilia—Epirubicin—pancreatic cancer	0.000267	0.00121	CcSEcCtD
Granisetron—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000267	0.00121	CcSEcCtD
Granisetron—Dizziness—Sunitinib—pancreatic cancer	0.000264	0.0012	CcSEcCtD
Granisetron—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000264	0.0012	CcSEcCtD
Granisetron—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000264	0.0012	CcSEcCtD
Granisetron—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000263	0.00119	CcSEcCtD
Granisetron—Angina pectoris—Epirubicin—pancreatic cancer	0.000263	0.00119	CcSEcCtD
Granisetron—Body temperature increased—Irinotecan—pancreatic cancer	0.00026	0.00118	CcSEcCtD
Granisetron—Abdominal pain—Irinotecan—pancreatic cancer	0.00026	0.00118	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.00026	0.00118	CcSEcCtD
Granisetron—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00026	0.00118	CcSEcCtD
Granisetron—Anaemia—Docetaxel—pancreatic cancer	0.000258	0.00117	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000255	0.00116	CcSEcCtD
Granisetron—Vomiting—Sunitinib—pancreatic cancer	0.000254	0.00115	CcSEcCtD
Granisetron—Body temperature increased—Gemcitabine—pancreatic cancer	0.000253	0.00115	CcSEcCtD
Granisetron—Dysuria—Epirubicin—pancreatic cancer	0.000252	0.00115	CcSEcCtD
Granisetron—Rash—Sunitinib—pancreatic cancer	0.000252	0.00114	CcSEcCtD
Granisetron—Dermatitis—Sunitinib—pancreatic cancer	0.000252	0.00114	CcSEcCtD
Granisetron—Abdominal distension—Doxorubicin—pancreatic cancer	0.000251	0.00114	CcSEcCtD
Granisetron—Urticaria—Fluorouracil—pancreatic cancer	0.00025	0.00114	CcSEcCtD
Granisetron—Headache—Sunitinib—pancreatic cancer	0.00025	0.00114	CcSEcCtD
Granisetron—Syncope—Docetaxel—pancreatic cancer	0.00025	0.00113	CcSEcCtD
Granisetron—Leukopenia—Docetaxel—pancreatic cancer	0.00025	0.00113	CcSEcCtD
Granisetron—Body temperature increased—Fluorouracil—pancreatic cancer	0.000249	0.00113	CcSEcCtD
Granisetron—Eosinophilia—Doxorubicin—pancreatic cancer	0.000247	0.00112	CcSEcCtD
Granisetron—Palpitations—Docetaxel—pancreatic cancer	0.000246	0.00112	CcSEcCtD
Granisetron—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000246	0.00112	CcSEcCtD
Granisetron—Loss of consciousness—Docetaxel—pancreatic cancer	0.000245	0.00111	CcSEcCtD
Granisetron—Cough—Docetaxel—pancreatic cancer	0.000243	0.0011	CcSEcCtD
Granisetron—Angina pectoris—Doxorubicin—pancreatic cancer	0.000243	0.0011	CcSEcCtD
Granisetron—Hypersensitivity—Irinotecan—pancreatic cancer	0.000242	0.0011	CcSEcCtD
Granisetron—Hypertension—Docetaxel—pancreatic cancer	0.000241	0.00109	CcSEcCtD
Granisetron—Arthralgia—Docetaxel—pancreatic cancer	0.000237	0.00108	CcSEcCtD
Granisetron—Chest pain—Docetaxel—pancreatic cancer	0.000237	0.00108	CcSEcCtD
Granisetron—Nausea—Sunitinib—pancreatic cancer	0.000237	0.00108	CcSEcCtD
Granisetron—Asthenia—Irinotecan—pancreatic cancer	0.000236	0.00107	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000236	0.00107	CcSEcCtD
Granisetron—Jaundice—Epirubicin—pancreatic cancer	0.000235	0.00106	CcSEcCtD
Granisetron—Urinary tract infection—Epirubicin—pancreatic cancer	0.000234	0.00106	CcSEcCtD
Granisetron—Dysuria—Doxorubicin—pancreatic cancer	0.000233	0.00106	CcSEcCtD
Granisetron—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000232	0.00105	CcSEcCtD
Granisetron—Dry mouth—Docetaxel—pancreatic cancer	0.000232	0.00105	CcSEcCtD
Granisetron—Sweating—Epirubicin—pancreatic cancer	0.000231	0.00105	CcSEcCtD
Granisetron—Asthenia—Gemcitabine—pancreatic cancer	0.00023	0.00104	CcSEcCtD
Granisetron—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000228	0.00103	CcSEcCtD
Granisetron—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000228	0.00103	CcSEcCtD
Granisetron—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000228	0.00103	CcSEcCtD
Granisetron—Oedema—Docetaxel—pancreatic cancer	0.000228	0.00103	CcSEcCtD
Granisetron—Epistaxis—Epirubicin—pancreatic cancer	0.000227	0.00103	CcSEcCtD
Granisetron—Pruritus—Gemcitabine—pancreatic cancer	0.000227	0.00103	CcSEcCtD
Granisetron—Infection—Docetaxel—pancreatic cancer	0.000226	0.00103	CcSEcCtD
Granisetron—Sinusitis—Epirubicin—pancreatic cancer	0.000226	0.00102	CcSEcCtD
Granisetron—Diarrhoea—Irinotecan—pancreatic cancer	0.000225	0.00102	CcSEcCtD
Granisetron—Shock—Docetaxel—pancreatic cancer	0.000224	0.00102	CcSEcCtD
Granisetron—Nervous system disorder—Docetaxel—pancreatic cancer	0.000223	0.00101	CcSEcCtD
Granisetron—Pruritus—Fluorouracil—pancreatic cancer	0.000223	0.00101	CcSEcCtD
Granisetron—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000223	0.00101	CcSEcCtD
Granisetron—Tachycardia—Docetaxel—pancreatic cancer	0.000222	0.00101	CcSEcCtD
Granisetron—Skin disorder—Docetaxel—pancreatic cancer	0.000221	0.001	CcSEcCtD
Granisetron—Bradycardia—Epirubicin—pancreatic cancer	0.00022	0.000998	CcSEcCtD
Granisetron—Diarrhoea—Gemcitabine—pancreatic cancer	0.000219	0.000995	CcSEcCtD
Granisetron—Dizziness—Irinotecan—pancreatic cancer	0.000218	0.000988	CcSEcCtD
Granisetron—Jaundice—Doxorubicin—pancreatic cancer	0.000217	0.000985	CcSEcCtD
Granisetron—Rhinitis—Epirubicin—pancreatic cancer	0.000217	0.000983	CcSEcCtD
Granisetron—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000216	0.000982	CcSEcCtD
Granisetron—Diarrhoea—Fluorouracil—pancreatic cancer	0.000216	0.000979	CcSEcCtD
Granisetron—Sweating—Doxorubicin—pancreatic cancer	0.000213	0.000968	CcSEcCtD
Granisetron—Hypotension—Docetaxel—pancreatic cancer	0.000213	0.000965	CcSEcCtD
Granisetron—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000212	0.000963	CcSEcCtD
Granisetron—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000211	0.000955	CcSEcCtD
Granisetron—Epistaxis—Doxorubicin—pancreatic cancer	0.00021	0.000953	CcSEcCtD
Granisetron—Vomiting—Irinotecan—pancreatic cancer	0.000209	0.00095	CcSEcCtD
Granisetron—Sinusitis—Doxorubicin—pancreatic cancer	0.000209	0.000948	CcSEcCtD
Granisetron—Dizziness—Fluorouracil—pancreatic cancer	0.000208	0.000946	CcSEcCtD
Granisetron—Visual impairment—Epirubicin—pancreatic cancer	0.000208	0.000945	CcSEcCtD
Granisetron—Rash—Irinotecan—pancreatic cancer	0.000208	0.000942	CcSEcCtD
Granisetron—Dermatitis—Irinotecan—pancreatic cancer	0.000207	0.000941	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000207	0.000941	CcSEcCtD
Granisetron—Headache—Irinotecan—pancreatic cancer	0.000206	0.000936	CcSEcCtD
Granisetron—Insomnia—Docetaxel—pancreatic cancer	0.000206	0.000934	CcSEcCtD
Granisetron—Paraesthesia—Docetaxel—pancreatic cancer	0.000204	0.000927	CcSEcCtD
Granisetron—Vomiting—Gemcitabine—pancreatic cancer	0.000204	0.000925	CcSEcCtD
Granisetron—Bradycardia—Doxorubicin—pancreatic cancer	0.000203	0.000923	CcSEcCtD
Granisetron—Dyspnoea—Docetaxel—pancreatic cancer	0.000203	0.00092	CcSEcCtD
Granisetron—Somnolence—Docetaxel—pancreatic cancer	0.000202	0.000918	CcSEcCtD
Granisetron—Rash—Gemcitabine—pancreatic cancer	0.000202	0.000917	CcSEcCtD
Granisetron—Dermatitis—Gemcitabine—pancreatic cancer	0.000202	0.000916	CcSEcCtD
Granisetron—Headache—Gemcitabine—pancreatic cancer	0.000201	0.000911	CcSEcCtD
Granisetron—Flushing—Epirubicin—pancreatic cancer	0.0002	0.00091	CcSEcCtD
Granisetron—Vomiting—Fluorouracil—pancreatic cancer	0.0002	0.000909	CcSEcCtD
Granisetron—Rhinitis—Doxorubicin—pancreatic cancer	0.0002	0.000909	CcSEcCtD
Granisetron—Dyspepsia—Docetaxel—pancreatic cancer	0.0002	0.000909	CcSEcCtD
Granisetron—Rash—Fluorouracil—pancreatic cancer	0.000199	0.000902	CcSEcCtD
Granisetron—Dermatitis—Fluorouracil—pancreatic cancer	0.000199	0.000901	CcSEcCtD
Granisetron—Decreased appetite—Docetaxel—pancreatic cancer	0.000198	0.000897	CcSEcCtD
Granisetron—Headache—Fluorouracil—pancreatic cancer	0.000197	0.000896	CcSEcCtD
Granisetron—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000196	0.000891	CcSEcCtD
Granisetron—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000196	0.000891	CcSEcCtD
Granisetron—Angiopathy—Epirubicin—pancreatic cancer	0.000196	0.000889	CcSEcCtD
Granisetron—Nausea—Irinotecan—pancreatic cancer	0.000196	0.000887	CcSEcCtD
Granisetron—Constipation—Docetaxel—pancreatic cancer	0.000195	0.000883	CcSEcCtD
Granisetron—Pain—Docetaxel—pancreatic cancer	0.000195	0.000883	CcSEcCtD
Granisetron—Chills—Epirubicin—pancreatic cancer	0.000194	0.000879	CcSEcCtD
Granisetron—Arrhythmia—Epirubicin—pancreatic cancer	0.000193	0.000876	CcSEcCtD
Granisetron—Visual impairment—Doxorubicin—pancreatic cancer	0.000193	0.000874	CcSEcCtD
Granisetron—Alopecia—Epirubicin—pancreatic cancer	0.000191	0.000866	CcSEcCtD
Granisetron—Nausea—Gemcitabine—pancreatic cancer	0.00019	0.000864	CcSEcCtD
Granisetron—Malnutrition—Epirubicin—pancreatic cancer	0.000188	0.000853	CcSEcCtD
Granisetron—Feeling abnormal—Docetaxel—pancreatic cancer	0.000187	0.000851	CcSEcCtD
Granisetron—Nausea—Fluorouracil—pancreatic cancer	0.000187	0.00085	CcSEcCtD
Granisetron—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000186	0.000844	CcSEcCtD
Granisetron—Flushing—Doxorubicin—pancreatic cancer	0.000185	0.000842	CcSEcCtD
Granisetron—Flatulence—Epirubicin—pancreatic cancer	0.000185	0.000841	CcSEcCtD
Granisetron—Tension—Epirubicin—pancreatic cancer	0.000185	0.000837	CcSEcCtD
Granisetron—Dysgeusia—Epirubicin—pancreatic cancer	0.000184	0.000836	CcSEcCtD
Granisetron—Nervousness—Epirubicin—pancreatic cancer	0.000183	0.000829	CcSEcCtD
Granisetron—Angiopathy—Doxorubicin—pancreatic cancer	0.000181	0.000823	CcSEcCtD
Granisetron—Abdominal pain—Docetaxel—pancreatic cancer	0.00018	0.000816	CcSEcCtD
Granisetron—Body temperature increased—Docetaxel—pancreatic cancer	0.00018	0.000816	CcSEcCtD
Granisetron—Chills—Doxorubicin—pancreatic cancer	0.000179	0.000814	CcSEcCtD
Granisetron—Arrhythmia—Doxorubicin—pancreatic cancer	0.000179	0.00081	CcSEcCtD
Granisetron—Alopecia—Doxorubicin—pancreatic cancer	0.000177	0.000801	CcSEcCtD
Granisetron—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000174	0.000792	CcSEcCtD
Granisetron—Malnutrition—Doxorubicin—pancreatic cancer	0.000174	0.000789	CcSEcCtD
Granisetron—Anaemia—Epirubicin—pancreatic cancer	0.000174	0.000789	CcSEcCtD
Granisetron—Agitation—Epirubicin—pancreatic cancer	0.000173	0.000784	CcSEcCtD
Granisetron—Flatulence—Doxorubicin—pancreatic cancer	0.000171	0.000778	CcSEcCtD
Granisetron—Tension—Doxorubicin—pancreatic cancer	0.000171	0.000775	CcSEcCtD
Granisetron—Dysgeusia—Doxorubicin—pancreatic cancer	0.00017	0.000773	CcSEcCtD
Granisetron—Malaise—Epirubicin—pancreatic cancer	0.00017	0.000769	CcSEcCtD
Granisetron—Nervousness—Doxorubicin—pancreatic cancer	0.000169	0.000767	CcSEcCtD
Granisetron—Vertigo—Epirubicin—pancreatic cancer	0.000169	0.000767	CcSEcCtD
Granisetron—Syncope—Epirubicin—pancreatic cancer	0.000169	0.000765	CcSEcCtD
Granisetron—Leukopenia—Epirubicin—pancreatic cancer	0.000168	0.000764	CcSEcCtD
Granisetron—Hypersensitivity—Docetaxel—pancreatic cancer	0.000168	0.000761	CcSEcCtD
Granisetron—Palpitations—Epirubicin—pancreatic cancer	0.000166	0.000754	CcSEcCtD
Granisetron—Loss of consciousness—Epirubicin—pancreatic cancer	0.000165	0.00075	CcSEcCtD
Granisetron—Cough—Epirubicin—pancreatic cancer	0.000164	0.000745	CcSEcCtD
Granisetron—Asthenia—Docetaxel—pancreatic cancer	0.000163	0.000741	CcSEcCtD
Granisetron—Hypertension—Epirubicin—pancreatic cancer	0.000162	0.000737	CcSEcCtD
Granisetron—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000161	0.000732	CcSEcCtD
Granisetron—Pruritus—Docetaxel—pancreatic cancer	0.000161	0.00073	CcSEcCtD
Granisetron—Anaemia—Doxorubicin—pancreatic cancer	0.000161	0.00073	CcSEcCtD
Granisetron—Chest pain—Epirubicin—pancreatic cancer	0.00016	0.000726	CcSEcCtD
Granisetron—Arthralgia—Epirubicin—pancreatic cancer	0.00016	0.000726	CcSEcCtD
Granisetron—Agitation—Doxorubicin—pancreatic cancer	0.00016	0.000725	CcSEcCtD
Granisetron—Anxiety—Epirubicin—pancreatic cancer	0.00016	0.000724	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000159	0.000721	CcSEcCtD
Granisetron—Discomfort—Epirubicin—pancreatic cancer	0.000158	0.000718	CcSEcCtD
Granisetron—Malaise—Doxorubicin—pancreatic cancer	0.000157	0.000712	CcSEcCtD
Granisetron—Dry mouth—Epirubicin—pancreatic cancer	0.000157	0.00071	CcSEcCtD
Granisetron—Vertigo—Doxorubicin—pancreatic cancer	0.000156	0.000709	CcSEcCtD
Granisetron—Syncope—Doxorubicin—pancreatic cancer	0.000156	0.000708	CcSEcCtD
Granisetron—Leukopenia—Doxorubicin—pancreatic cancer	0.000156	0.000707	CcSEcCtD
Granisetron—Diarrhoea—Docetaxel—pancreatic cancer	0.000156	0.000706	CcSEcCtD
Granisetron—Palpitations—Doxorubicin—pancreatic cancer	0.000154	0.000698	CcSEcCtD
Granisetron—Oedema—Epirubicin—pancreatic cancer	0.000153	0.000696	CcSEcCtD
Granisetron—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000153	0.000696	CcSEcCtD
Granisetron—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000153	0.000694	CcSEcCtD
Granisetron—Infection—Epirubicin—pancreatic cancer	0.000152	0.000692	CcSEcCtD
Granisetron—Cough—Doxorubicin—pancreatic cancer	0.000152	0.000689	CcSEcCtD
Granisetron—Shock—Epirubicin—pancreatic cancer	0.000151	0.000685	CcSEcCtD
Granisetron—Nervous system disorder—Epirubicin—pancreatic cancer	0.00015	0.000683	CcSEcCtD
Granisetron—Dizziness—Docetaxel—pancreatic cancer	0.00015	0.000683	CcSEcCtD
Granisetron—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00015	0.000682	CcSEcCtD
Granisetron—Hypertension—Doxorubicin—pancreatic cancer	0.00015	0.000682	CcSEcCtD
Granisetron—Tachycardia—Epirubicin—pancreatic cancer	0.00015	0.00068	CcSEcCtD
Granisetron—Skin disorder—Epirubicin—pancreatic cancer	0.000149	0.000676	CcSEcCtD
Granisetron—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000148	0.000673	CcSEcCtD
Granisetron—Chest pain—Doxorubicin—pancreatic cancer	0.000148	0.000672	CcSEcCtD
Granisetron—Arthralgia—Doxorubicin—pancreatic cancer	0.000148	0.000672	CcSEcCtD
Granisetron—Anxiety—Doxorubicin—pancreatic cancer	0.000148	0.00067	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000147	0.000667	CcSEcCtD
Granisetron—Discomfort—Doxorubicin—pancreatic cancer	0.000146	0.000664	CcSEcCtD
Granisetron—Dry mouth—Doxorubicin—pancreatic cancer	0.000145	0.000657	CcSEcCtD
Granisetron—Vomiting—Docetaxel—pancreatic cancer	0.000145	0.000656	CcSEcCtD
Granisetron—Rash—Docetaxel—pancreatic cancer	0.000143	0.000651	CcSEcCtD
Granisetron—Hypotension—Epirubicin—pancreatic cancer	0.000143	0.000651	CcSEcCtD
Granisetron—Dermatitis—Docetaxel—pancreatic cancer	0.000143	0.00065	CcSEcCtD
Granisetron—Headache—Docetaxel—pancreatic cancer	0.000143	0.000647	CcSEcCtD
Granisetron—Oedema—Doxorubicin—pancreatic cancer	0.000142	0.000644	CcSEcCtD
Granisetron—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000142	0.000644	CcSEcCtD
Granisetron—Infection—Doxorubicin—pancreatic cancer	0.000141	0.00064	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00014	0.000634	CcSEcCtD
Granisetron—Shock—Doxorubicin—pancreatic cancer	0.00014	0.000634	CcSEcCtD
Granisetron—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000139	0.000632	CcSEcCtD
Granisetron—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000139	0.000631	CcSEcCtD
Granisetron—Insomnia—Epirubicin—pancreatic cancer	0.000139	0.00063	CcSEcCtD
Granisetron—Tachycardia—Doxorubicin—pancreatic cancer	0.000139	0.000629	CcSEcCtD
Granisetron—Skin disorder—Doxorubicin—pancreatic cancer	0.000138	0.000626	CcSEcCtD
Granisetron—Paraesthesia—Epirubicin—pancreatic cancer	0.000138	0.000625	CcSEcCtD
Granisetron—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000137	0.000623	CcSEcCtD
Granisetron—Dyspnoea—Epirubicin—pancreatic cancer	0.000137	0.000621	CcSEcCtD
Granisetron—Somnolence—Epirubicin—pancreatic cancer	0.000136	0.000619	CcSEcCtD
Granisetron—Nausea—Docetaxel—pancreatic cancer	0.000135	0.000613	CcSEcCtD
Granisetron—Dyspepsia—Epirubicin—pancreatic cancer	0.000135	0.000613	CcSEcCtD
Granisetron—Decreased appetite—Epirubicin—pancreatic cancer	0.000133	0.000605	CcSEcCtD
Granisetron—Hypotension—Doxorubicin—pancreatic cancer	0.000133	0.000602	CcSEcCtD
Granisetron—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000132	0.000601	CcSEcCtD
Granisetron—Constipation—Epirubicin—pancreatic cancer	0.000131	0.000595	CcSEcCtD
Granisetron—Pain—Epirubicin—pancreatic cancer	0.000131	0.000595	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000129	0.000587	CcSEcCtD
Granisetron—Insomnia—Doxorubicin—pancreatic cancer	0.000128	0.000583	CcSEcCtD
Granisetron—Paraesthesia—Doxorubicin—pancreatic cancer	0.000128	0.000579	CcSEcCtD
Granisetron—Dyspnoea—Doxorubicin—pancreatic cancer	0.000127	0.000574	CcSEcCtD
Granisetron—Feeling abnormal—Epirubicin—pancreatic cancer	0.000126	0.000574	CcSEcCtD
Granisetron—Somnolence—Doxorubicin—pancreatic cancer	0.000126	0.000573	CcSEcCtD
Granisetron—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000125	0.000569	CcSEcCtD
Granisetron—Dyspepsia—Doxorubicin—pancreatic cancer	0.000125	0.000567	CcSEcCtD
Granisetron—Decreased appetite—Doxorubicin—pancreatic cancer	0.000123	0.00056	CcSEcCtD
Granisetron—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000123	0.000556	CcSEcCtD
Granisetron—Urticaria—Epirubicin—pancreatic cancer	0.000122	0.000553	CcSEcCtD
Granisetron—Constipation—Doxorubicin—pancreatic cancer	0.000121	0.000551	CcSEcCtD
Granisetron—Pain—Doxorubicin—pancreatic cancer	0.000121	0.000551	CcSEcCtD
Granisetron—Body temperature increased—Epirubicin—pancreatic cancer	0.000121	0.00055	CcSEcCtD
Granisetron—Abdominal pain—Epirubicin—pancreatic cancer	0.000121	0.00055	CcSEcCtD
Granisetron—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000117	0.000531	CcSEcCtD
Granisetron—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000116	0.000527	CcSEcCtD
Granisetron—Hypersensitivity—Epirubicin—pancreatic cancer	0.000113	0.000513	CcSEcCtD
Granisetron—Urticaria—Doxorubicin—pancreatic cancer	0.000113	0.000512	CcSEcCtD
Granisetron—Body temperature increased—Doxorubicin—pancreatic cancer	0.000112	0.000509	CcSEcCtD
Granisetron—Abdominal pain—Doxorubicin—pancreatic cancer	0.000112	0.000509	CcSEcCtD
Granisetron—Asthenia—Epirubicin—pancreatic cancer	0.00011	0.0005	CcSEcCtD
Granisetron—Pruritus—Epirubicin—pancreatic cancer	0.000109	0.000493	CcSEcCtD
Granisetron—Diarrhoea—Epirubicin—pancreatic cancer	0.000105	0.000476	CcSEcCtD
Granisetron—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000105	0.000475	CcSEcCtD
Granisetron—Asthenia—Doxorubicin—pancreatic cancer	0.000102	0.000462	CcSEcCtD
Granisetron—Dizziness—Epirubicin—pancreatic cancer	0.000101	0.00046	CcSEcCtD
Granisetron—Pruritus—Doxorubicin—pancreatic cancer	0.0001	0.000456	CcSEcCtD
Granisetron—Vomiting—Epirubicin—pancreatic cancer	9.76e-05	0.000443	CcSEcCtD
Granisetron—Diarrhoea—Doxorubicin—pancreatic cancer	9.72e-05	0.000441	CcSEcCtD
Granisetron—Rash—Epirubicin—pancreatic cancer	9.68e-05	0.000439	CcSEcCtD
Granisetron—Dermatitis—Epirubicin—pancreatic cancer	9.67e-05	0.000439	CcSEcCtD
Granisetron—Headache—Epirubicin—pancreatic cancer	9.61e-05	0.000436	CcSEcCtD
Granisetron—Dizziness—Doxorubicin—pancreatic cancer	9.39e-05	0.000426	CcSEcCtD
Granisetron—Nausea—Epirubicin—pancreatic cancer	9.12e-05	0.000414	CcSEcCtD
Granisetron—Vomiting—Doxorubicin—pancreatic cancer	9.03e-05	0.00041	CcSEcCtD
Granisetron—Rash—Doxorubicin—pancreatic cancer	8.95e-05	0.000406	CcSEcCtD
Granisetron—Dermatitis—Doxorubicin—pancreatic cancer	8.94e-05	0.000406	CcSEcCtD
Granisetron—Headache—Doxorubicin—pancreatic cancer	8.9e-05	0.000404	CcSEcCtD
Granisetron—Nausea—Doxorubicin—pancreatic cancer	8.43e-05	0.000383	CcSEcCtD
